Health Care, Law & Legal, Lifestyle, Science

VANDA Pharmaceuticals recently announces FDA grants Orphan Drug Designation for VGT-1849B, a novel and selective candidate for the treatment of Polycythemia Vera

WASHINGTON — PRNewswire — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) on Aug. 28, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849B, a selective peptide nucleic acid-based JAK2 inhibitor for the treatment of polycythemia vera (PV).

Business, Cultural Corner, Health Care, Law & Legal

Euromonitor International: More than 75% of global e-vapor volume is driven by illicit market

LONDON, United Kingdom – The illicit e-vapour market is valued at 47 million litres, equivalent to 605 billion sticks and accounts for three-quarters of total e-vapour volume globally, data analytics company Euromonitor International has revealed. According to Euromonitor International’s World Market for Nicotine 2025 report, the rise